Skip to main content Skip to main navigation menu Skip to site footer

Patogenesis dan diagnosis immune reconstitution inflammatory syndrome tuberculosis

  • Gede Wira Mahadita ,
  • I Ketut Agus Somia ,


Progressive increase in the incidence of tuberculosis (TB) and its coinfection with human immunodeficiency virus (HIV) is observed. Immune system restoration related to highly active antiretroviral therapy (HAART) can cause an immunopathologic reaction termed immune reconstitution inflammatory syndrome (IRIS)-TB. Many aspects of the IRIS phenomenon remain unraveled since its first discovery in 1954. This review is intended to summarize available evidence on various aspects of IRIS with particular focus on its pathogenesis and diagnosis.


Insiden tuberkulosis (TB) dan koinfeksinya dengan infeksi human immunodeficiency virus (HIV) terus meningkat dari tahun ke tahun. Perbaikan imunitas yang berhubungan dengan highly active antiretroviral therapy (HAART) dapat disertai dengan reaksi imunopatologis yang disebut sebagai immune reconstitution inflammatory syndrome (IRIS)-TB. Perkembangan pengetahuan mengenai IRIS sejak fenomena ini pertama kali ditemukan pada tahun 1954 masih belum sempurna. Tinjauan ini bertujuan untuk merangkum literatur yang tersedia mengenai beragam aspek IRIS dengan fokus pada aspek patogenesis dan diagnosis.


  1. World health organization. Global Tuberculosis Reports. 2013;1-97.
  2. Diedrich, CR and Flynn, JA. HIV-1/Mycobacterium Tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?. Infect Immun. 2011;79(4):1407-82.
  3. Manabe Y, Breen R, Perti T, Girardi E & Sterling TR. Unmasked Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Diseases: A Disease Spectrum after Initiation of Antiretroviral Therapy. The Journal of Infectious Diseases. 2009;199:437-44.
  4. Meintjes G, Lawn SD, Scano F, Maartens AF et al. Tuberculosis Associated Immune Reconstitution Syndrome: Case Definition for Use in Resource-Limited Settings. Lancet Infect Dis. 2008;8(8):516-23.
  5. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger, M et al. Immune Reconstitution Inflammatory Syndrome in Patients Starting Antiretroviral Therapy for HIV Infection: A Systematic Review and Meta-Analysis. Lancet Infect Dis. 2010;10:251–261.
  6. Fernandes GC, Vieira MA, Lourenc¸o MC, Gadelha AJ, Coura LC, Rolla VC. Inflammatory Paradoxical Reaction Occurring In Tuberculosis Patients Treated with HAART and Rifampicin. Rev Inst Med Trop Sao Paulo. 2002;44:113–4.
  7. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical Worsening Of Tuberculosis Following Antiretroviral Therapy In Patients with AIDS. Am J Respir Crit Care Med 1998;158:157–61.
  8. Wendel KA, Alwood KS, Gachuhi R, Chaisson RE, Bishai WR, Sterling TR. Paradoxical Worsening Of Tuberculosis In HIV-Infected Persons. Chest. 2001;120:193–7.
  9. Haddow LJ, Moosa M-YS, Mosam A, Moodley P, Parboosing R, et al. Incidence, Clinical Spectrum, Risk Factors and Impact of HIV-Associated Immune Reconstitution Inflammatory Syndrome in South Africa. PLoS ONE. 2012;7(11):e40623.
  10. Fishman JE, Saraf-Lavi E, Narita M, Hollender ES, Ramsinghani R, Ashkin D. Pulmonary Tuberculosis In AIDS Patients: Transient Chest Radiographic Worsening After Initiation Of Antiretroviral Therapy. AJR Am J Roentgenol. 2000;174:43–9.
  11. Furrer H, Malinverni R. Systemic Inflammatory Reaction After Starting Highly Active Antiretroviral Therapy In AIDS Patients Treated For Extrapulmonary Tuberculosis. Am J Med. 1999;106:371–2.
  12. Smith CJ , Sabin CA, Lampe FC, Konloch-de-Loes S, Gumley H, Caroll A et al. The Potential dor CD4 Cell Increases in HIV-Positive Individuals who Control Viremia with HAART. AIDS. 2003;17:963-9.
  13. Kaufmann GR, Perin L, Pantaleo G, Opravil M, Firrer H, Telenti A et al. CD4-T Lymphocyte Recovery in Individuals with Advanced HIV-1Infection Receiving Potent Antiretroviral Therapy for 4 years: The Swiss HIV Cohort Study. Arch Intern Med. 2003;163:2187-95.
  14. Abbas AK, Lichtman AH & Phillai S. Cellular and Mollecular Immunology. 6th ed. Philadelpia. Saunder Elsevier. 2007; 176-85.
  15. Bourgarit A, Carcelain G, MArtinez V, Lascoux C, Delcey V, Gicuel B & Vicaut. Explotion of Tuberculin Spesific Th-1 Response Induces Immune Restoration Syndrome Who Treated With HAART. AIDS. 2006;20:F1-F7.
  16. Sutton CE, Mielke L A. and Mills K H. IL-17-producing gammadelta T cells and innate lymphoid cells. Eur J Immunol. 2012;42:2221–31.
  17. Eliiot JH. Immuno Pathogenesis and diagnosis of Tuberculosis and Tuberculosis-Associated Immune Reconstitution Syndrome During Early Antiretroviral Therapy. J Infect Dis. 209;200:1736-45
  18. Skolimowska, Rangaka MX, Meintjes G et al. Altered Ratio of IFN-gamma/Il-10 in Patients with Drug Resistant Mycobacterium Tuberculosis and HIV-Tuberculosis Immune Reconstitution Syndrome. PlosOne. 2008;7:464-81
  19. Lim A, D’Orsogna L, Price P and French MA. Imbalanced Effector and Regulatory Cytokines Response may Underlie Mycobcaterium Immune Restoration Diseases. AIDS Res. 2008;5:9.
  20. Tadikera R, Meitjes G, Skolimowska KH, Wolkinson KA, Matthews K, Seldon R et al. Hypercytokinemia Acompanies HIV-Tuberculosis Immune reconstitution Syndrome. Eur Respir J. 2011;37:1248-59.
  21. Tadikera R, Meitjes G, Skolimowska KH, Wolkinson KA, Matthews K, Seldon R et al. Hypercytokinemia Acompanies HIV-Tuberculosis Immune reconstitution Syndrome. Eur Respir J. 2011;37:1248-59.
  22. Rubino S J, Geddes K. and Girardin S E.Innate IL-17 and IL- 22 responses to enteric bacterial pathogens. Trends Immunol. 2012;33:112–118.
  23. Affandi J S, Kumar M, Agarwal U, Singh S. and Price P. The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis. Dis Markers. 2013;34:445–9.
  24. Van den Bergh R, Vanham G, Raes G, De Baetselier P. and Colebunders R. Mycobacterium-Associated Immune Reconstitution Disease: Macrophages Running Wild? Lancet Infect Dis. 2006;6:2–3.
  25. Lawn SD, Wainwright H and. Orrell C. Fatal Unmasking Tuberculosis Immune Reconstitution Disease With Bronchiolitis Obliterans Organizing Pneumonia: The Role Of Macrophages. AIDS. 2009;23:143–145.
  26. Janeway CA and Medzhitov R. Innate Immune Recognition. Annu. Rev. Immunol. 2002. 20: 197–216.
  27. Conradie F, Foulkes AS, Ive P, Yin X, Roussos K, Glencross DK, Lawrie D. et al. Natural Killer Cell Activation Distinguishes Mycobacterium Tuberculosis-Mediated Immune Reconstitution Syndrome From Chronic HIV And HIV/MTB Coinfection. J Acquir Immune Defic Syndr. 2011;58:309–318.
  28. Haddow LJ, Dibben O, Moosa MY, Borrow P. and Easterbrook PJ. Circulating Inflammatory Biomarkers Can Predict And Characterize Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. AIDS. 2011;25:1163–1174.
  29. Porter BO, Ouedraogo GL, Hodge JN, Smith MA, Pau A, Roby G, Kwan R. et al. D-Dimer And CRP Levels Are Elevated Prior To Antiretroviral Treatment In Patients Who Develop IRIS. Clin Immunol. 2010;136:42–50.
  30. Tran HT, Van den Bergh R, Loembe MM, Worodria W, Mayanja-Kizza H, Colebunders R, Mascart F. et al. Modulation Of The Complement System In Monocytes Contributes To Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome. AIDS. 2013;27:1725–1734.
  31. Reiling N, Holscher C, Fehrenbach A, Kroger S, Kirschning CJ, Goyert S. and Ehlers S. Cutting edge: Toll-Like Receptor (TLR)2- And TLR4-Mediated Pathogen Recognition In Resistance To Airborne Infection With Mycobacterium Tuberculosis. J Immunol. 2002;169:3480–3484.
  32. Tan DB, Lim A, Yong YK, Ponnampalavanar S, Omar S, Kamarulzaman A, French MA. et al. TLR2-Induced Cytokine Responses May Characterize HIV-Infected Patients Experiencing Mycobacterial Immune Restoration Disease. AIDS. 2011;25:1455–1460.
  33. Pean P, Nerrienet E, Madec Y, Borand L, Laureillard D, Fernandez M, Marcy O. et al. Natural Killer Cell Degranulation Capacity Predicts Early Onset Of The Immune Reconstitution Inflammatory Syndrome (IRIS) In HIV-Infected Patients With Tuberculosis. Blood. 2012;119:3315–3320.
  34. Marais S, Meintjes G, Pepper DJ, Dodd LE, Schutz C, Ismail Z, Wilkinson KA. et al. Frequency, Severity, And Prediction Of Tuberculous Meningitis Immune Reconstitution Inflammatory Syndrome. Clin Infect Dis. 2013;56: 450–460.
  35. Simonney N, Dewulf G, Herrmann JL, Gutierrez MC, Vicaut E, Boutron C, Leportier M. et al. Anti-PGL-Tb1 Responses As An Indicator Of The Immune Restoration Syndrome In HIV-TB Patients. Tuberculosis (Edinb). 2008;88: 453–461.
  36. Manosuthi W, Kiertiburanakul S, Phoorisri T, Sungkanuparph S. Immune Reconstitution Inflammatory Syndrome Of Tuberculosis Among HIV-Infected Patients Receiving Antituberculous And Antiretroviral Therapy. J Infect. 2006;53:357–63.
  37. Navas E, Mart?´n-Da´ vila P, Moreno L, Pintado V, Casado JL, Fortu´ n J, et al. Paradoxical Reactions Of Tuberculosis In Patients With The Acquired Immunodeficiency Syndrome Who Are Treated With Highly Active Antiretroviral Therapy. Arch Intern Med. 2002;162:97–9.
  38. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray AL, Gengiah T et al. Integration Of Antiretroviral Therapy With Tuberculosis Treatment. N Engl J Med. 2011;365:1492–1501.
  39. Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y. et al. Earlier Versus Later Start Of Antiretroviral Therapy In HIV-Infected Adults With Tuberculosis. N Engl J Med. 2011;365:1471–1481.
  40. Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer A. F. et al. Timing Of Antiretroviral Therapy For HIV-1 Infection And Tuberculosis. N Engl J Med. 2011;365:1482–1491.
  41. Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, et al. Incidence And Risk Factors For Immune Reconstitution Inflammatory Syndrome During Highly Active Antiretroviral Therapy. AIDS. 2005;19:399–406.
  42. Murdoch DM, Venter WD, Feldman C, Van Rie A. Incidence And Risk Factors For The Immune Reconstitution Inflammatory Syndrome In HIV Patients In South Africa A Prospective Study. AIDS. 2008;22:601–10.
  43. Olalla J, Pulido F, Rubio R, Costa MA, Monsalvo R, Palenque E, et al. Paradoxical Responses In A Cohort Of HIV-1-Infected Patients With Mycobacterial Disease. Int J Tuberc Lung Dis. 2002;6:71–5.
  44. Colebunders R, John L, Huyst V, Kambugu A, Scano F, Lynen L. Tuberculosis Immune Reconstitution Inflammatory Syndrome In Countries With Limited Resources. Int J Tuberc Lung Dis. 2006;10:946–53.
  45. French MA, Price P, Stone SF. Immune Restoration Disease After Antiretroviral Therapy. AIDS. 2004;18:1615–27.
  46. Burman WJ, Jones BE. Treatment Of HIV-Related Tuberculosis In The Era Of Effective Antiretroviral Therapy. Am J Respir Crit Care Med. 2001;164:7–12.

How to Cite

Mahadita, G. W., & Somia, I. K. A. (2020). Patogenesis dan diagnosis immune reconstitution inflammatory syndrome tuberculosis. Intisari Sains Medis, 11(3), 1492–1499.




Search Panel

Gede Wira Mahadita
Google Scholar
ISM Journal

I Ketut Agus Somia
Google Scholar
ISM Journal